Rhinitis: all 1,101 studies

Page 7 of 12. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.

• 4"S" - Seasonal Symptoms Suppression StudyStatus unknownNCT02557269Phase 4
• Tolerability of SLIT With LAIS® 2-Tree Allergoid TabletsCompletedNCT02553590
• Efficacy and Safety of HCP1102 CapsuleCompletedNCT02552667Phase 3
• Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic RhinitisCompletedNCT02551536Phase 4
• Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or LoratadineCompletedNCT02513290Phase 4
• Anti-inflammatory H1 Antihistamines Allergic RhinitisCompletedNCT02507635Phase 4
• The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and AcupunctureCompletedNCT02486159Not applicable
• Birch-SPIRE Safety and Efficacy StudyCompletedNCT02478060Phase 2
• The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean MedicineCompletedNCT02477293Phase 4
• Detection and Use of Nasal Nitrous Oxide and the Electronic NoseCompletedNCT02476929Not applicable
• Trial of Tian Jiu Therapy for Allergic RhinitisCompletedNCT02470845Not applicable
• Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis PatientsCompletedNCT02461797Not applicable
• Preventing Atopic Dermatitis and ALLergies in ChildrenActive, not recruitingNCT02449850Not applicable
• Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®CompletedNCT02437786Phase 4
• Safety and Efficacy Study of Intralymphatic Allergen-specific ImmunotherapyCompletedNCT02423707Phase 2/3
• Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic RhinitisCompletedNCT02409563Phase 4
• CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in ChildrenCompletedNCT02409550
• A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic RhinitisCompletedNCT02401191Phase 3
• "Studio NaVA" - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without AsthmaCompletedNCT02380495
• Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic RhinitisCompletedNCT02377895Phase 1/2
• Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without AsthmaCompletedNCT02360072
• Airway Inflammation in Children With Allergic Rhinitis and InterventionCompletedNCT02352168Not applicable
• Clinical Validation of Birch Pollen in the EEUCompletedNCT02351830Not applicable
• Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic AsthmaCompletedNCT02340130Phase 2
• Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic RhinitisCompletedNCT02339714Phase 2
• Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal CancerCompletedNCT02338102Not applicable
• Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic RhinitisCompletedNCT02301884Phase 1
• Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without ConjunctivitisCompletedNCT02295969
• Korean Linguistic Adaptation of Rhinitis Controlled Assessment TestCompletedNCT02279706
• A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic RhinitisStatus unknownNCT02279563Phase 2
• The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored TurbinateStatus unknownNCT02278081Phase 4
• A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic RhinitisCompletedNCT02273817Phase 3
• Rhinitis in the Elderly: The Role of Vitamin DCompletedNCT02272101Phase 3
• The Prevalence and Clinical Characteristics of Children With Local Allergic RhinitisCompletedNCT02271620Not applicable
• Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis PatientsTerminatedNCT02269566Phase 1
• Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial AsthmaCompletedNCT02255136Not applicable
• Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™Status unknownNCT02249663Phase 3
• Possible Manifestation of Rhinitis After Nasal FractureActive, not recruitingNCT02240576
• AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)Status unknownNCT02238353Phase 4
• Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and PruritusCompletedNCT02238236
• Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® TabletCompletedNCT02238223
• Effect of Hypertonic Solutions on Allergic Rhinitis PatientsStatus unknownNCT02233426
• SUBLIVAC FIX Birch Phase III Short-term EfficacyCompletedNCT02231307Phase 3
• Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.CompletedNCT02230475
• The Role of Th9 Cells and Eosinophils Activity in Allergic Airway DiseasesStatus unknownNCT02214303
• The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled StudyStatus unknownNCT02192645Phase 3
• WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic RhinitisCompletedNCT02182544Phase 3
• Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic RhinitisCompletedNCT02182518Phase 3
• Evaluation of Efficacy of Dellegra in Exposure UnitCompletedNCT02175485Phase 4
• Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge ChamberCompletedNCT02166268Phase 2
• Study of Grass-SPIRE in Subjects With Grass Allergies and AsthmaCompletedNCT02161107Phase 2
• Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal EsketamineCompletedNCT02154334Phase 1
• Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisCompletedNCT02148744Phase 1
• A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 DeviceCompletedNCT02146781Phase 1
• Kinetic Oscillation Stimulation (KOS) of Nasal Mucosa in Non-allergic Rhinitis: Investigation of Treatment ProcedureCompletedNCT02136043Not applicable
• Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal SprayCompletedNCT02133053
• Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic RhinitisCompletedNCT02130440Phase 3
• Efficacy of a Depigmented Extract of Phleum in Local Allergic RhinitisCompletedNCT02126111Phase 2
• The Effect of Exercises on Physiological Changes and Clinical Symptoms in Allergic Rhinitis PatientsCompletedNCT02123914Not applicable
• Subcutaneous Immunotherapy With Dermatophagoides Pteronyssinus in Local Allergic RhinitisCompletedNCT02123316Phase 2
• A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female VolunteersCompletedNCT02109185Phase 1
• Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay FeverCompletedNCT02108574Not applicable
• Compliance and Usability Study Evaluating RHINIX™ Nasal FiltersCompletedNCT02108379Not applicable
• StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind StudyStatus unknownNCT02082054Phase 2
• Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure ChamberCompletedNCT02061709Phase 2
• Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and AsthmaCompletedNCT02061670Phase 2
• International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic RhinitisTerminatedNCT02041624
• Allergen Immunotherapy in Allergic PatientsStatus unknownNCT02040974
• Acupuncture for Rhinitis Complicated With AsthmaStatus unknownNCT02033252Not applicable
• Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat AsthmaCompletedNCT02029313Phase 1
• Controlled Trial of Chinese Herbal Medicine to Treat Allergic RhinitisCompletedNCT02027194Phase 1/2
• Post Marketing Surveillance for Contac Bien Z in JapanCompletedNCT02020902
• Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic RhinitisCompletedNCT02014623Phase 4
• Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in ThailandCompletedNCT02000648
• House Dust Mite Allergen Reduction in Bedding: Purotex Impregnated Covers of Bekaert TextilesCompletedNCT01997606Not applicable
• Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin TestsWithdrawnNCT01989897Phase 1/2
• NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic RhinitisCompletedNCT01986582Phase 2
• Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)CompletedNCT01983865Not applicable
• Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in KoreanCompletedNCT01982916Phase 3
• Safety of Lymph Node Injection for Allergen ImmunotherapyStatus unknownNCT01982474Phase 1
• Leukotriene D4 Nasal Provocation Test in Allergic RhinitisCompletedNCT01963741Not applicable
• A Relative Bioavailability Study of Fluticasone Furoate and LevocabastineCompletedNCT01962467Phase 1
• Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)CompletedNCT01953471
• Alpha-Blockers in Allergic Rhinitis (MAN 01)CompletedNCT01946035Phase 4
• Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite AllergenCompletedNCT01936818
• PURETHAL Birch RUSH StudyCompletedNCT01918956Phase 4
• Assessing Risk of Food Insecurity Within Households of Children With Food AllergyCompletedNCT01897506
• PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mgCompletedNCT01897428Phase 1
• Immunological Comparison of AIT and SCIT Immunotherapy Against Grass PollenCompletedNCT01889875Not applicable
• The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy ReactionsStatus unknownNCT01878929Phase 1/2
• Evaluating the Need for New Rhinitis TreatmentCompletedNCT01875276
• Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and ControlsCompletedNCT01862523Phase 4
• Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral LyophilisateCompletedNCT01854736Phase 4
• Evaluation of an Integrated Care ProjectCompletedNCT01854580
• Is There a Comorbidity Between Migraine and Allergic Rhinitis?CompletedNCT01845051
• PBASE System Idiopathic Rhinitis Clinical InvestigationCompletedNCT01844336Not applicable
• Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical CorticosteroidsStatus unknownNCT01839851
• Biological Standardization of Dermatophagoides Pteronyssinus Allergen ExtractCompletedNCT01821716Phase 2
• PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic DiseasesStatus unknownNCT01805635
• A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure ChamberCompletedNCT01804400Phase 2

← Rhinitis overview